+171.3%
MRVL vs RCAT
+340.1%
-168.8%
-60.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.7% | +18.6% | -12.9% | +3.3% |
| 7D | -28.1% | -12.7% | -15.4% | -26.8% |
| 30D | -50.4% | -34.3% | -16.1% | -47.7% |
| 3M | -32.9% | -53.4% | +20.5% | -26.8% |
| 6M | -17.9% | -62.0% | +44.0% | -8.6% |
| YTD | +66.4% | -49.1% | +115.5% | +76.8% |
| 1Y | +51.5% | -53.1% | +104.7% | +61.1% |
| All | +171.3% | +340.1% | -168.8% | +174.0% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling